» Authors » Naohide Kurita

Naohide Kurita

Explore the profile of Naohide Kurita including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 190
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Niiyama S, Ueno Y, Kurita N, Nakajima S, Kijima C, Hira K, et al.
J Stroke Cerebrovasc Dis . 2024 Oct; 33(12):108048. PMID: 39476743
Purpose: A high-risk patent foramen ovale (PFO) could be the cause of cryptogenic stroke, and an atrial septal aneurysm (ASA) increases the risk of stroke recurrence in cryptogenic stroke patients...
2.
Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Nakamura R, et al.
Mov Disord Clin Pract . 2024 Jan; 11(4):352-362. PMID: 38264844
Background: Chronic constipation is a common digestive complication of Parkinson's disease (PD). Objectives: To verify the usefulness of elobixibat, an ileal bile acid transporter inhibitor, for chronic constipation in PD....
3.
Inaba T, Yamashiro K, Kurita N, Ueno Y, Miyamoto N, Hira K, et al.
CNS Neurosci Ther . 2023 Jun; 29 Suppl 1:200-212. PMID: 37287396
Aims: White matter lesions (WMLs) are involved in the pathological processes leading to cognitive decline and dementia. We examined the mechanisms underlying the exacerbation of ischemia-induced cognitive impairment and WMLs...
4.
Hira K, Ueno Y, Watanabe M, Shimura H, Kurita N, Miyamoto N, et al.
BMC Neurol . 2022 Sep; 22(1):338. PMID: 36076175
Background: Embolic stroke of undetermined source (ESUS) encompasses diverse embologenic mechanisms, which transesophageal echocardiography (TEE) is critical to detect. Specific markers related to each embolic source in ESUS is not...
5.
Nakajima S, Kawano H, Yamashiro K, Tanaka R, Kameda T, Kurita N, et al.
Front Neurol . 2022 Apr; 13:868137. PMID: 35444612
Background And Objective: Hypercoagulability is associated with increased risks of ischemic stroke and subsequent mortality in patients with active cancer. This study investigated the relationships between plasma D-dimer levels after...
6.
Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Fukae J, et al.
BMJ Open . 2022 Feb; 12(2):e054129. PMID: 35149566
Introduction: Chronic constipation worsens the quality of life (QOL) of patients with Parkinson's disease (PD). Elobixibat, an ileal bile acid transporter inhibitor, is a useful laxative, but its effect on...
7.
Shimizu M, Ogaki K, Nakamura R, Kado E, Nakajima S, Kurita N, et al.
eNeurologicalSci . 2021 Nov; 25:100381. PMID: 34841097
A global pandemic has resulted from the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). To control the spread of SARS-CoV-2 infection,...
8.
Shimada T, Nakajima S, Nakamura R, Kurita N, Ogaki K, Watanabe M, et al.
eNeurologicalSci . 2021 Oct; 25:100370. PMID: 34660918
Hashimoto's encephalopathy (HE) is a steroid-responsive encephalopathy characterized by several neurological symptoms. HE mainly involves the central nervous system; the peripheral nervous system is rarely involved. We treated a previously...
9.
Yamashiro K, Kurita N, Urabe T, Hattori N
Ann Nutr Metab . 2021 Jun; 77 Suppl 2:36-44. PMID: 34107468
Background: Major advances have been made in stroke treatment and prevention in the past decades. However, the burden of stroke remains high. Identification of novel targets and establishment of effective...
10.
Nakajima S, Tanaka R, Yamashiro K, Chiba A, Noto D, Inaba T, et al.
J Am Heart Assoc . 2021 Mar; 10(7):e018803. PMID: 33733818
Background Mucosal-associated invariant T (MAIT) cells have been associated with inflammation in several autoimmune diseases. However, their relation to ischemic stroke remains unclear. This study attempted to elucidate the role...